These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30253201)

  • 41. Stem cell-based Lung-on-Chips: The best of both worlds?
    Nawroth JC; Barrile R; Conegliano D; van Riet S; Hiemstra PS; Villenave R
    Adv Drug Deliv Rev; 2019 Feb; 140():12-32. PubMed ID: 30009883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
    Donoghue L; Nguyen KT; Graham C; Sethu P
    Micromachines (Basel); 2021 Jan; 12(2):. PubMed ID: 33525451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging microphysiological systems: a review.
    Peel S; Jackman M
    Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comment on pluripotent stem cells in next-generation biomedical theranostics.
    Rossbach M
    Curr Mol Med; 2013 Jun; 13(5):879-83. PubMed ID: 23642068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery.
    Christensen K; Roudnicky F; Patsch C; Burcin M
    Adv Biochem Eng Biotechnol; 2018; 163():207-220. PubMed ID: 29071405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human brain microphysiological systems in the study of neuroinfectious disorders.
    Barreras P; Pamies D; Hartung T; Pardo CA
    Exp Neurol; 2023 Jul; 365():114409. PubMed ID: 37061175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells.
    Lauschke K; Frederiksen L; Hall VJ
    Stem Cells Dev; 2017 Jun; 26(12):857-874. PubMed ID: 28398169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induced Pluripotent Stem Cell (iPSC)-Derived Endothelial Cells to Study Bacterial-Brain Endothelial Cell Interactions.
    Espinal ER; Sharp SJ; Kim BJ
    Methods Mol Biol; 2022; 2492():73-101. PubMed ID: 35733039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling Group B
    Kim BJ; Bee OB; McDonagh MA; Stebbins MJ; Palecek SP; Doran KS; Shusta EV
    mSphere; 2017; 2(6):. PubMed ID: 29104935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.
    Tang S; Xie M; Cao N; Ding S
    J Med Chem; 2016 Jan; 59(1):2-15. PubMed ID: 26322868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality.
    Patel R; Page S; Al-Ahmad AJ
    J Neurochem; 2017 Jul; 142(1):74-88. PubMed ID: 28397247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of induced pluripotent stem cells in drug development.
    Inoue H; Yamanaka S
    Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
    Tzatzalos E; Abilez OJ; Shukla P; Wu JC
    Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microphysiological systems for recapitulating physiology and function of blood-brain barrier.
    Seo S; Kim H; Sung JH; Choi N; Lee K; Kim HN
    Biomaterials; 2020 Feb; 232():119732. PubMed ID: 31901694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pumped and pumpless microphysiological systems to study (nano)therapeutics.
    Lee EJ; Krassin ZL; Abaci HE; Mahler GJ; Esch MB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1911. PubMed ID: 37464464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient-derived induced pluripotent stem cells in cancer research and precision oncology.
    Papapetrou EP
    Nat Med; 2016 Dec; 22(12):1392-1401. PubMed ID: 27923030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineering Tissues from Induced Pluripotent Stem Cells.
    Loskill P; Huebsch N
    Tissue Eng Part A; 2019 May; 25(9-10):707-710. PubMed ID: 31030627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.